Taiho Oncology, Inc.
- Home
- Companies
- Taiho Oncology, Inc.
- Products
- Futibatinib - Model FGFR 1-4 - ...
Futibatinib - Model FGFR 1-4 -Inhibitor
Tumors with specific FGFR aberrations: Solid tumors, Gastric cancer, Myelolymphoid neoplasms PHASE 2.
Most popular related searches
non-small cell lung cancer
gastric cancer
solid tumor
lung cancer
tumor specificity
lung cell
cancerous mutation
cancerous tumor
cancer cell
- Urothelial cancer in combination with pembrolizumab PHASE 2
- Non-small cell lung cancer with KRAS mutations in combination with binimetinib PHASE 2